Peter Pitts to Newsmax: Alzheimer’s Drug on Track for FDA Approval

Former Food and Drug Administration Associate Commissioner Peter Pitts told Newsmax that the drug Lecanemab’s progress is “good news” for Alzheimer patients and their families.

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.